WWM
AVNS

Wolff Wiese Magana’s Avanos Medical AVNS Stock Holding History

Wolff Wiese Magana’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-16
Closed -$409 – 803
2023
Q2 		$409 Sell
16
-15
-48% -$395 ﹤0.01% 713
2023
Q1 		$922 Hold
31
– – ﹤0.01% 582
2022
Q4 		$839 Buy
+31
New +$758 ﹤0.01% 591

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wolff Wiese Magana's AVNS Position: Q3 2023 in Review

Wolff Wiese Magana sold out of Avanos Medical (AVNS) in Q3 2023, closing a stake of 16 shares — an estimated $409 sold.

Wolff Wiese Magana first reported a position in AVNS in Q4 2022 and held it in 3 quarters. The position peaked at $922 in Q1 2023. 260 funds tracked by Wall St. Rank hold AVNS as of Q3 2023.

  • Wolff Wiese Magana reported no remaining Avanos Medical position as of Q3 2023 after selling out during the quarter.
  • Wolff Wiese Magana sold 16 Avanos Medical shares in Q3 2023, an estimated $409.
  • Wolff Wiese Magana first reported a position in Avanos Medical in Q4 2022 and held it in 3 quarters.
  • Wolff Wiese Magana's Avanos Medical position peaked at $922 in Q1 2023.
  • 260 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2023.

Based on Wolff Wiese Magana's 13F filing for Q3 2023, filed 31 Oct 2023.